Bio/Pharma News

Pharma News in Global Health and Sustainability

December 04, 2013

PTSM: Pharmaceutical Technology Sourcing and Management

A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

Merck KGaA Invests in Research Partnerships in Israel

November 27, 2013

Additional companies join Merck KGaA and Neviah Genomics in the Israel BioIncubator.

Lilly Funds Start Up of Biosciences Research Institute

November 27, 2013

The Indiana Biosciences Research Institute will accelerate collaboration and focus on human-health solutions.

Sanofi Discontinues Fedratinib Development

November 26, 2013

Sanofi discontinues development for its investigational JAK2 inhibitor, fedratinib.

GSK and Amicus Therapeutics Revise Migalastat Agreement

November 26, 2013

GSK and Amicus Therapeutics revise Fabry agreement entered into in July 2012.

Merck KGaA Invests in China, Global HQ

November 25, 2013

Merck KGaA plans to build a new biomanufacturing facility in Nantong, China.

Pfizer to Close Manufacturing Plant in Puerto Rico by 2017

November 22, 2013

Manufacturing of products made at the Barceloneta, Puerto Rico plant will be moved to other sites.

Shire To Acquire Rare-Disease Company ViroPharma

November 11, 2013

Shire-s agreement to acquire ViroPharma will strengthen its rare-disease portfolio.

Pfizer, Carter Center Partner in Global Health Project

November 11, 2013

Former President Jimmy Carter and Pfizer mark milestone for long-standing partnership to combat trachoma in the developing world.

Novartis Announced as Facility of the Year Awards Overall Winner

November 06, 2013

ISPE names Novartis' US Flu Cell Culture facility as award winner.